“CNP Protein as Potential Antiviral Target for SARS-CoV-2, Inhibiting Virion Assembly without Affecting Protein Translation”

https://pubmed.ncbi.nlm.nih.gov/38117830

A protein called CNP has the potential to be a new antiviral target for SARS-CoV-2, as it inhibits virion assembly and reduces intracellular titers without affecting viral protein translation, and targeting it to mitochondria is necessary for inhibition.